Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities

Early purification protocols for C-reactive protein (CRP) often involved co-isolation of lipoproteins, primarily very low-density lipoproteins (VLDLs). The interaction with lipid particles was initially attributed to CRP’s calcium-dependent binding affinity for its primary ligand—phosphocholine—the...

Full description

Bibliographic Details
Main Authors: Lawrence A. Potempa, Wei Qiao Qiu, Ashley Stefanski, Ibraheem M. Rajab
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.979461/full
_version_ 1828112349494509568
author Lawrence A. Potempa
Wei Qiao Qiu
Wei Qiao Qiu
Wei Qiao Qiu
Ashley Stefanski
Ibraheem M. Rajab
author_facet Lawrence A. Potempa
Wei Qiao Qiu
Wei Qiao Qiu
Wei Qiao Qiu
Ashley Stefanski
Ibraheem M. Rajab
author_sort Lawrence A. Potempa
collection DOAJ
description Early purification protocols for C-reactive protein (CRP) often involved co-isolation of lipoproteins, primarily very low-density lipoproteins (VLDLs). The interaction with lipid particles was initially attributed to CRP’s calcium-dependent binding affinity for its primary ligand—phosphocholine—the predominant hydrophilic head group expressed on phospholipids of most lipoprotein particles. Later, CRP was shown to additionally express binding affinity for apolipoprotein B (apo B), a predominant apolipoprotein of both VLDL and LDL particles. Apo B interaction with CRP was shown to be mediated by a cationic peptide sequence in apo B. Optimal apo B binding required CRP to be surface immobilized or aggregated, treatments now known to structurally change CRP from its serum soluble pentamer isoform (i.e., pCRP) into its poorly soluble, modified, monomeric isoform (i.e., mCRP). Other cationic ligands have been described for CRP which affect complement activation, histone bioactivities, and interactions with membranes. mCRP, but not pCRP, binds cholesterol and activates signaling pathways that activate pro-inflammatory bioactivities long associated with CRP as a biomarker. Hence, a key step to express CRP’s biofunctions is its conversion into its mCRP isoform. Conversion occurs when (1) pCRP binds to a membrane surface expressed ligand (often phosphocholine); (2) biochemical forces associated with binding cause relaxation/partial dissociation of secondary and tertiary structures into a swollen membrane bound intermediate (described as mCRPm or pCRP*); (3) further structural relaxation which leads to total, irreversible dissociation of the pentamer into mCRP and expression of a cholesterol/multi-ligand binding sequence that extends into the subunit core; (4) reduction of the CRP subunit intrachain disulfide bond which enhances CRP’s binding accessibility for various ligands and activates acute phase proinflammatory responses. Taken together, the biofunctions of CRP involve both lipid and protein interactions and a conformational rearrangement of higher order structure that affects its role as a mediator of inflammatory responses.
first_indexed 2024-04-11T11:48:49Z
format Article
id doaj.art-8eefcc8b62bc423e93f47cd61e7119b6
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-11T11:48:49Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-8eefcc8b62bc423e93f47cd61e7119b62022-12-22T04:25:27ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-09-01910.3389/fcvm.2022.979461979461Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activitiesLawrence A. Potempa0Wei Qiao Qiu1Wei Qiao Qiu2Wei Qiao Qiu3Ashley Stefanski4Ibraheem M. Rajab5College of Science, Health and Pharmacy, Roosevelt University Schaumburg, Schaumburg, IL, United StatesDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, United StatesAlzheimer’s Disease Center, Boston University School of Medicine, Boston, MA, United StatesDepartment of Psychiatry, Boston University School of Medicine, Boston, MA, United StatesCollege of Science, Health and Pharmacy, Roosevelt University Schaumburg, Schaumburg, IL, United StatesCollege of Science, Health and Pharmacy, Roosevelt University Schaumburg, Schaumburg, IL, United StatesEarly purification protocols for C-reactive protein (CRP) often involved co-isolation of lipoproteins, primarily very low-density lipoproteins (VLDLs). The interaction with lipid particles was initially attributed to CRP’s calcium-dependent binding affinity for its primary ligand—phosphocholine—the predominant hydrophilic head group expressed on phospholipids of most lipoprotein particles. Later, CRP was shown to additionally express binding affinity for apolipoprotein B (apo B), a predominant apolipoprotein of both VLDL and LDL particles. Apo B interaction with CRP was shown to be mediated by a cationic peptide sequence in apo B. Optimal apo B binding required CRP to be surface immobilized or aggregated, treatments now known to structurally change CRP from its serum soluble pentamer isoform (i.e., pCRP) into its poorly soluble, modified, monomeric isoform (i.e., mCRP). Other cationic ligands have been described for CRP which affect complement activation, histone bioactivities, and interactions with membranes. mCRP, but not pCRP, binds cholesterol and activates signaling pathways that activate pro-inflammatory bioactivities long associated with CRP as a biomarker. Hence, a key step to express CRP’s biofunctions is its conversion into its mCRP isoform. Conversion occurs when (1) pCRP binds to a membrane surface expressed ligand (often phosphocholine); (2) biochemical forces associated with binding cause relaxation/partial dissociation of secondary and tertiary structures into a swollen membrane bound intermediate (described as mCRPm or pCRP*); (3) further structural relaxation which leads to total, irreversible dissociation of the pentamer into mCRP and expression of a cholesterol/multi-ligand binding sequence that extends into the subunit core; (4) reduction of the CRP subunit intrachain disulfide bond which enhances CRP’s binding accessibility for various ligands and activates acute phase proinflammatory responses. Taken together, the biofunctions of CRP involve both lipid and protein interactions and a conformational rearrangement of higher order structure that affects its role as a mediator of inflammatory responses.https://www.frontiersin.org/articles/10.3389/fcvm.2022.979461/fullC-reactive protein (CRP)mCRPapolipoproteins (apoB)apolipoprotein EinflammationpCRP
spellingShingle Lawrence A. Potempa
Wei Qiao Qiu
Wei Qiao Qiu
Wei Qiao Qiu
Ashley Stefanski
Ibraheem M. Rajab
Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities
Frontiers in Cardiovascular Medicine
C-reactive protein (CRP)
mCRP
apolipoproteins (apoB)
apolipoprotein E
inflammation
pCRP
title Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities
title_full Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities
title_fullStr Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities
title_full_unstemmed Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities
title_short Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities
title_sort relevance of lipoproteins membranes and extracellular vesicles in understanding c reactive protein biochemical structure and biological activities
topic C-reactive protein (CRP)
mCRP
apolipoproteins (apoB)
apolipoprotein E
inflammation
pCRP
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.979461/full
work_keys_str_mv AT lawrenceapotempa relevanceoflipoproteinsmembranesandextracellularvesiclesinunderstandingcreactiveproteinbiochemicalstructureandbiologicalactivities
AT weiqiaoqiu relevanceoflipoproteinsmembranesandextracellularvesiclesinunderstandingcreactiveproteinbiochemicalstructureandbiologicalactivities
AT weiqiaoqiu relevanceoflipoproteinsmembranesandextracellularvesiclesinunderstandingcreactiveproteinbiochemicalstructureandbiologicalactivities
AT weiqiaoqiu relevanceoflipoproteinsmembranesandextracellularvesiclesinunderstandingcreactiveproteinbiochemicalstructureandbiologicalactivities
AT ashleystefanski relevanceoflipoproteinsmembranesandextracellularvesiclesinunderstandingcreactiveproteinbiochemicalstructureandbiologicalactivities
AT ibraheemmrajab relevanceoflipoproteinsmembranesandextracellularvesiclesinunderstandingcreactiveproteinbiochemicalstructureandbiologicalactivities